BioVentrix, Inc.

To spotlight the most innovative start-ups in the medtech space as we move into 2021, Medtech Insight is reflecting on 2020 to see which companies piqued the highest interest among readers. Our most

BioVentrix Inc. believes its Revivent TC transcatheter ventricular enhancement system represents a breakthrough in technology for reshaping the left ventricle of a failing heart and is supporting mul

Heart failure (HF), the leading cause of hospitalization in Americans over age 65, is both progressive and progressing. Driven by the aging population and an increase in ischemic heart disease, hypert

Each year, START-UP reviews the sectors of the medical device industry that received private funding to identify investment trends and to discover what will be fueling the growth of medtech strategi